New Results

In vitro evaluation of therapeutic antibodies against a SARS-CoV-2 Omicron B.1.1.529 isolate

Franck Touret, Cécile Baronti, Hawa Sophia Bouzidi, Xavier de Lamballerie
doi: https://doi.org/10.1101/2022.01.01.474639

Article usage

Article usage: January 2022 to March 2025

AbstractFullPdf
Jan 20222059333842
Feb 202229944149
Mar 20222774493
Apr 20221433650
May 2022811031
Jun 202274414
Jul 20225729
Aug 202244318
Sep 202245716
Oct 20223267
Nov 202234715
Dec 20221838
Jan 202319108
Feb 20233686
Mar 20232464
Apr 20231402
May 20231842
Jun 2023613
Jul 2023945
Aug 20231228
Sep 20238417
Oct 202320133
Nov 20238210
Dec 20232038
Jan 2024131311
Feb 20249933
Mar 202415276
Apr 202416223
May 20247053
Jun 202411713
Jul 20241377
Aug 20248511
Sep 2024904
Oct 2024910
Nov 20241214
Dec 2024901
Jan 2025404
Feb 20251534
Mar 2025413
Back to top
Posted January 03, 2022.
Download PDF
Email
In vitro evaluation of therapeutic antibodies against a SARS-CoV-2 Omicron B.1.1.529 isolate
Franck Touret, Cécile Baronti, Hawa Sophia Bouzidi, Xavier de Lamballerie
bioRxiv 2022.01.01.474639; doi: https://doi.org/10.1101/2022.01.01.474639
Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools

Subject Area